Sanofi 13D/13G Filings for LAVA Therapeutics N.V. (LVTX)

Sanofi 13D and 13G filings for LAVA Therapeutics N.V.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-03-31
11:19 am
Purchase
2021-03-2513GLAVA Therapeutics N.V.
LVTX
Sanofi1,919,455
7.000%
1,919,455increase
(New Position)
Filing